HSCS
Price
$3.17
Change
+$0.07 (+2.27%)
Updated
Oct 14, 11:11 AM (EDT)
Capitalization
21.46M
57 days until earnings call
Intraday BUY SELL Signals
HSDT
Price
$2.29
Change
-$0.06 (-2.55%)
Updated
Oct 14, 11:10 AM (EDT)
Capitalization
171.7M
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HSCS vs HSDT

HSCS vs HSDT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HSCS vs. HSDT commentary
Oct 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSCS is a Hold and HSDT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for HSCS with price predictions
Oct 13, 2026

HSCS's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for HSCS moved out of overbought territory on September 21, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 instances where the indicator moved out of the overbought zone. In 14 of the 15 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HSCS as a result. In 68 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for HSCS turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 37 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

HSCS moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSCS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +8.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where HSCS advanced for three days, in 143 of 173 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

HSCS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 29 of 43 cases where HSCS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. HSCS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: HSCS's P/B Ratio (70.848) is slightly higher than the industry average of (10.930). P/E Ratio (0.549) is within average values for comparable stocks, (100.178). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. HSCS's P/S Ratio (2500.000) is very high in comparison to the industry average of (40.124).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSCS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for HSDT with price predictions
Oct 13, 2026

HSDT in +1.14% Uptrend, growing for three consecutive days on October 06, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HSDT advanced for three days, in 169 of 202 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Aroon Indicator entered an Uptrend today. In 60 of 81 cases where HSDT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.

Bearish Trend Analysis

The 10-day RSI Indicator for HSDT moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 similar instances where the indicator moved out of overbought territory. In 9 of the 10 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Momentum Indicator moved below the 0 level on October 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HSDT as a result. In 76 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for HSDT turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 34 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSDT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

HSDT broke above its upper Bollinger Band on September 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. HSDT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.012) is normal, around the industry mean (3.263). P/E Ratio (0.014) is within average values for comparable stocks, (27.022). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). HSDT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.081). P/S Ratio (11.574) is also within normal values, averaging (15.860).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

FUNDAMENTALS RATINGS
HSDT: Fundamental Ratings
HSDT
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HSCSHSDT
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
74%
COMPARISON
Comparison
Oct 14, 2026
Stock price -- (HSCS: $3.09 vs. HSDT: $2.35)
Brand notoriety: HSCS and HSDT are both not notable
HSCS represents the Medical/Nursing Services, while HSDT is part of the Investment Managers industry
Current volume relative to the 65-day Moving Average: HSCS: 72% vs. HSDT: 39%
Market capitalization -- HSCS: $21.46M vs. HSDT: $171.7M
HSCS [@Medical/Nursing Services] is valued at $21.46M. HSDT’s [@Investment Managers] market capitalization is $171.7M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $174.73B. The market cap for tickers in the [@Investment Managers] industry ranges from $57 to $165.9B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.59B. The average market capitalization across the [@Investment Managers] industry is $8.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HSCS’s FA Score shows that 0 FA rating(s) are green while HSDT’s FA Score has 1 green FA rating(s).

  • HSCS’s FA Score: 0 green, 5 red.
  • HSDT’s FA Score: 1 green, 4 red.
According to our system of comparison, HSDT is a better buy in the long-term than HSCS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HSCS’s TA Score shows that 4 TA indicator(s) are bullish while HSDT’s TA Score has 3 bullish TA indicator(s).

  • HSCS’s TA Score: 4 bullish, 5 bearish.
  • HSDT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, HSCS is a better buy in the short-term than HSDT.

Price Growth

HSCS (@Medical/Nursing Services) experienced а -18.04% price change this week, while HSDT (@Investment Managers) price change was -11.65% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.54%. For the same industry, the average monthly price growth was -6.26%, and the average quarterly price growth was -14.18%.

The average weekly price growth across all stocks in the @Investment Managers industry was -3.42%. For the same industry, the average monthly price growth was -2.82%, and the average quarterly price growth was -3.87%.

Reported Earning Dates

HSCS is expected to report earnings on Dec 10, 2026.

HSDT is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical/Nursing Services (-3.54% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Investment Managers (-3.42% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

View a ticker or compare two or three
HSCS
Daily Signal:
Gain/Loss:
HSDT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
A171.600.27
+0.16%
Agilent Technologies
COPL10.57N/A
N/A
Copley Acquisition Corp
NPK146.79-1.55
-1.04%
National Presto Industries
HLNE82.92-3.99
-4.59%
Hamilton Lane
JSPR0.50-0.06
-10.70%
Jasper Therapeutics

HSCS and

Correlation & Price change

A.I.dvisor tells us that HSCS and HSDT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSCS and HSDT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSCS
1D Price
Change %
HSCS100%
-6.36%
HSDT - HSCS
32%
Poorly correlated
-1.67%
PSNL - HSCS
22%
Poorly correlated
+0.32%
MYO - HSCS
21%
Poorly correlated
-5.15%
AEMD - HSCS
21%
Poorly correlated
-4.78%
CLPT - HSCS
21%
Poorly correlated
-3.82%
More

HSDT and

Correlation & Price change

A.I.dvisor indicates that over the last year, HSDT has been loosely correlated with MLCI. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if HSDT jumps, then MLCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSDT
1D Price
Change %
HSDT100%
-1.67%
MLCI - HSDT
60%
Loosely correlated
+1.65%
DFDV - HSDT
56%
Loosely correlated
-1.85%
ASST - HSDT
45%
Loosely correlated
-0.43%
AMBR - HSDT
33%
Poorly correlated
+6.52%
HSCS - HSDT
32%
Poorly correlated
-6.36%
More